These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 15368293
1. Human in vivo-activated CD45R0(+) CD4(+) T cells are susceptible to spontaneous apoptosis that can be inhibited by the chemokine CXCL12 and IL-2, -6, -7, and -15. Pajusto M, Ihalainen N, Pelkonen J, Tarkkanen J, Mattila PS. Eur J Immunol; 2004 Oct; 34(10):2771-80. PubMed ID: 15368293 [Abstract] [Full Text] [Related]
2. Human primary adenotonsillar naïve phenotype CD45RA CD4 T lymphocytes undergo apoptosis upon stimulation with a high concentration of CD3 antibody. Pajusto M, Tarkkanen J, Mattila PS. Scand J Immunol; 2005 Dec; 62(6):546-51. PubMed ID: 16316422 [Abstract] [Full Text] [Related]
3. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway. Colamussi ML, Secchiero P, Gonelli A, Marchisio M, Zauli G, Capitani S. J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277 [Abstract] [Full Text] [Related]
4. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells. Kishimoto H, Sprent J. J Immunol; 1999 Aug 15; 163(4):1817-26. PubMed ID: 10438914 [Abstract] [Full Text] [Related]
5. Differential expression of the cytokine receptors for human interleukin (IL)-12 and IL-18 on lymphocytes of both CD45RA and CD45RO phenotype from tonsils, cord and adult peripheral blood. Bofill M, Almirall E, McQuaid A, Peña R, Ruiz-Hernandez R, Naranjo M, Ruiz L, Clotet B, Borràs FE. Clin Exp Immunol; 2004 Dec 15; 138(3):460-5. PubMed ID: 15544623 [Abstract] [Full Text] [Related]
6. In vitro responses of human CD45R0brightRA- and CD45R0-RAbright T cell subsets and their relationship to memory and naive T cells. Young JL, Ramage JM, Gaston JS, Beverley PC. Eur J Immunol; 1997 Sep 15; 27(9):2383-90. PubMed ID: 9341784 [Abstract] [Full Text] [Related]
7. The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15). Rappl G, Abken H, Hasselmann DO, Tilgen W, Ugurel S, Reinhold U. Cell Death Differ; 2001 Apr 15; 8(4):395-402. PubMed ID: 11550091 [Abstract] [Full Text] [Related]
8. Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR. Cantó E, Rodriguez-Sanchez JL, Vidal S. J Leukoc Biol; 2003 Dec 15; 74(6):998-1007. PubMed ID: 12972509 [Abstract] [Full Text] [Related]
9. Phenotype transition of CD4+ T cells from CD45RA to CD45R0 is accompanied by cell activation and proliferation. Johannisson A, Festin R. Cytometry; 1995 Apr 01; 19(4):343-52. PubMed ID: 7796699 [Abstract] [Full Text] [Related]
10. IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes. Ferrari-Lacraz S, Chicheportiche R, Schneiter G, Molnarfi N, Villard J, Dayer JM. Int Immunol; 2008 Aug 01; 20(8):1009-18. PubMed ID: 18556671 [Abstract] [Full Text] [Related]
11. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Muppidi JR, Siegel RM. Nat Immunol; 2004 Feb 01; 5(2):182-9. PubMed ID: 14745445 [Abstract] [Full Text] [Related]
12. CD95-mediated apoptosis in naïve, central and effector memory subsets of CD4+ and CD8+ T cells in aged humans. Gupta S, Gollapudi S. Exp Gerontol; 2008 Apr 01; 43(4):266-74. PubMed ID: 18215485 [Abstract] [Full Text] [Related]
13. Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death. Brugnoni D, Airò P, Pennacchio M, Carella G, Malagoli A, Ugazio AG, Porta F, Cattaneo R. Bone Marrow Transplant; 1999 Mar 01; 23(5):451-7. PubMed ID: 10100558 [Abstract] [Full Text] [Related]
14. gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Masse GX, Corcuff E, Decaluwe H, Bommhardt U, Lantz O, Buer J, Di Santo JP. Eur J Immunol; 2007 Sep 01; 37(9):2606-16. PubMed ID: 17683114 [Abstract] [Full Text] [Related]
15. Resistance of CD45RA- T cells to apoptosis and functional impairment, and activation of tumor-antigen specific T cells during radiation therapy of prostate cancer. Tabi Z, Spary LK, Coleman S, Clayton A, Mason MD, Staffurth J. J Immunol; 2010 Jul 15; 185(2):1330-9. PubMed ID: 20548027 [Abstract] [Full Text] [Related]
16. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells. Lin SJ, Lee CC, Cheng PJ, See LC, Kuo ML. Pediatr Allergy Immunol; 2009 Jun 15; 20(4):392-8. PubMed ID: 18713315 [Abstract] [Full Text] [Related]
17. CD45 isoform expression is associated with different susceptibilities of human naive and effector CD4+ T cells to respond to IL-4. Stütz A, Graf P, Beinhauer B, Hammerschmid F, Neumann C, Woisetschläger M, Jung T. Eur J Immunol; 2005 Feb 15; 35(2):575-83. PubMed ID: 15682447 [Abstract] [Full Text] [Related]
18. In vitro cell death of activated lymphocytes in Omenn's syndrome. Brugnoni D, Airò P, Facchetti F, Blanzuoli L, Ugazio AG, Cattaneo R, Notarangelo LD. Eur J Immunol; 1997 Nov 15; 27(11):2765-73. PubMed ID: 9394797 [Abstract] [Full Text] [Related]
19. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW, Liao CH, Ying C, Chang CJ, Lin CM. Clin Immunol; 2006 Apr 15; 119(1):21-31. PubMed ID: 16406844 [Abstract] [Full Text] [Related]
20. G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice. Sabzevari H, Propp S, Kono DH, Theofilopoulos AN. Eur J Immunol; 1997 Aug 15; 27(8):1901-10. PubMed ID: 9295025 [Abstract] [Full Text] [Related] Page: [Next] [New Search]